UniProt ID | PLAP_HUMAN | |
---|---|---|
UniProt AC | Q9Y263 | |
Protein Name | Phospholipase A-2-activating protein | |
Gene Name | PLAA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 795 | |
Subcellular Localization | Nucleus . Cytoplasm . Cell junction, synapse . Recruited to damaged lysosomes decorated with K48-linked ubiquitin chains. | |
Protein Description | Plays a role in protein ubiquitination, sorting and degradation through its association with VCP. [PubMed: 27753622 Involved in ubiquitin-mediated membrane proteins trafficking to late endosomes in an ESCRT-dependent manner, and hence plays a role in synaptic vesicle recycling (By similarity May play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes] | |
Protein Sequence | MTSGATRYRLSCSLRGHELDVRGLVCCAYPPGAFVSVSRDRTTRLWAPDSPNRSFTEMHCMSGHSNFVSCVCIIPSSDIYPHGLIATGGNDHNICIFSLDSPMPLYILKGHKNTVCSLSSGKFGTLLSGSWDTTAKVWLNDKCMMTLQGHTAAVWAVKILPEQGLMLTGSADKTVKLWKAGRCERTFSGHEDCVRGLAILSETEFLSCANDASIRRWQITGECLEVYYGHTNYIYSISVFPNCRDFVTTAEDRSLRIWKHGECAQTIRLPAQSIWCCCVLDNGDIVVGASDGIIRVFTESEDRTASAEEIKAFEKELSHATIDSKTGDLGDINAEQLPGREHLNEPGTREGQTRLIRDGEKVEAYQWSVSEGRWIKIGDVVGSSGANQQTSGKVLYEGKEFDYVFSIDVNEGGPSYKLPYNTSDDPWLTAYNFLQKNDLNPMFLDQVAKFIIDNTKGQMLGLGNPSFSDPFTGGGRYVPGSSGSSNTLPTADPFTGAGRYVPGSASMGTTMAGVDPFTGNSAYRSAASKTMNIYFPKKEAVTFDQANPTQILGKLKELNGTAPEEKKLTEDDLILLEKILSLICNSSSEKPTVQQLQILWKAINCPEDIVFPALDILRLSIKHPSVNENFCNEKEGAQFSSHLINLLNPKGKPANQLLALRTFCNCFVGQAGQKLMMSQRESLMSHAIELKSGSNKNIHIALATLALNYSVCFHKDHNIEGKAQCLSLISTILEVVQDLEATFRLLVALGTLISDDSNAVQLAKSLGVDSQIKKYSSVSEPAKVSECCRFILNLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTSGATRYR ------CCCCCCEEE | 35.55 | 20860994 | |
3 | Phosphorylation | -----MTSGATRYRL -----CCCCCCEEEE | 25.73 | 20860994 | |
6 | Phosphorylation | --MTSGATRYRLSCS --CCCCCCEEEEEEE | 31.58 | - | |
8 | Phosphorylation | MTSGATRYRLSCSLR CCCCCCEEEEEEECC | 16.14 | 30631047 | |
13 | Phosphorylation | TRYRLSCSLRGHELD CEEEEEEECCCCEEE | 20.09 | 30631047 | |
50 | Phosphorylation | TRLWAPDSPNRSFTE CCEECCCCCCCCCCE | 24.02 | 30266825 | |
112 | Ubiquitination | LYILKGHKNTVCSLS EEEECCCCCEEEECC | 64.08 | 29967540 | |
122 | Ubiquitination | VCSLSSGKFGTLLSG EEECCCCCCCEECCC | 42.44 | 32015554 | |
125 | Phosphorylation | LSSGKFGTLLSGSWD CCCCCCCEECCCCCC | 27.88 | 27067055 | |
173 | Ubiquitination | MLTGSADKTVKLWKA EEECCCCCCEEEEEC | 55.74 | 29967540 | |
176 | Ubiquitination | GSADKTVKLWKAGRC CCCCCCEEEEECCCC | 54.59 | 27667366 | |
179 | Ubiquitination | DKTVKLWKAGRCERT CCCEEEEECCCCCCC | 51.94 | 27667366 | |
186 | Phosphorylation | KAGRCERTFSGHEDC ECCCCCCCCCCCHHH | 10.40 | 23312004 | |
188 | Phosphorylation | GRCERTFSGHEDCVR CCCCCCCCCCHHHHH | 38.33 | 23312004 | |
259 | Ubiquitination | DRSLRIWKHGECAQT HCCEEEEECCHHHCC | 39.08 | 21906983 | |
303 | Methylation | VFTESEDRTASAEEI EEECCCCCCCCHHHH | 28.30 | 115487723 | |
311 | Ubiquitination | TASAEEIKAFEKELS CCCHHHHHHHHHHHH | 50.75 | 23000965 | |
311 | Acetylation | TASAEEIKAFEKELS CCCHHHHHHHHHHHH | 50.75 | 25953088 | |
315 | Ubiquitination | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 23000965 | |
315 | Malonylation | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 26320211 | |
315 | Acetylation | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 23236377 | |
318 | Phosphorylation | KAFEKELSHATIDSK HHHHHHHHCCEECCC | 16.50 | 27251275 | |
325 | Ubiquitination | SHATIDSKTGDLGDI HCCEECCCCCCCCCC | 53.42 | 21906983 | |
326 | Phosphorylation | HATIDSKTGDLGDIN CCEECCCCCCCCCCC | 39.62 | 28857561 | |
361 | Ubiquitination | RLIRDGEKVEAYQWS EEEECCCEEEEEEEE | 51.40 | 29967540 | |
376 | Ubiquitination | VSEGRWIKIGDVVGS ECCCCEEEEEEEECC | 33.41 | 23000965 | |
383 | Phosphorylation | KIGDVVGSSGANQQT EEEEEECCCCCCCCC | 17.62 | 23403867 | |
384 | Phosphorylation | IGDVVGSSGANQQTS EEEEECCCCCCCCCC | 35.68 | 23403867 | |
390 | Phosphorylation | SSGANQQTSGKVLYE CCCCCCCCCCEEEEC | 29.68 | 23403867 | |
391 | Phosphorylation | SGANQQTSGKVLYEG CCCCCCCCCEEEECC | 32.07 | 23403867 | |
393 | Ubiquitination | ANQQTSGKVLYEGKE CCCCCCCEEEECCCE | 28.91 | 23000965 | |
396 | Phosphorylation | QTSGKVLYEGKEFDY CCCCEEEECCCEEEE | 26.14 | 28270605 | |
399 | Ubiquitination | GKVLYEGKEFDYVFS CEEEECCCEEEEEEE | 43.18 | 23000965 | |
403 | Phosphorylation | YEGKEFDYVFSIDVN ECCCEEEEEEEEECC | 14.55 | 28270605 | |
406 | Phosphorylation | KEFDYVFSIDVNEGG CEEEEEEEEECCCCC | 14.08 | 28270605 | |
415 | Phosphorylation | DVNEGGPSYKLPYNT ECCCCCCCCCCCCCC | 37.87 | 25627689 | |
436 | Ubiquitination | TAYNFLQKNDLNPMF HHHHHHHHCCCCHHH | 55.35 | 23503661 | |
449 | Ubiquitination | MFLDQVAKFIIDNTK HHHHHHHHHHCCCCC | 37.93 | 33845483 | |
456 | Acetylation | KFIIDNTKGQMLGLG HHHCCCCCCCEECCC | 54.09 | 7407777 | |
456 | Ubiquitination | KFIIDNTKGQMLGLG HHHCCCCCCCEECCC | 54.09 | 23000965 | |
459 | Sulfoxidation | IDNTKGQMLGLGNPS CCCCCCCEECCCCCC | 4.34 | 21406390 | |
466 | Phosphorylation | MLGLGNPSFSDPFTG EECCCCCCCCCCCCC | 41.19 | 28857561 | |
468 | Phosphorylation | GLGNPSFSDPFTGGG CCCCCCCCCCCCCCC | 49.03 | 28555341 | |
477 | Phosphorylation | PFTGGGRYVPGSSGS CCCCCCCCCCCCCCC | 17.80 | 30242111 | |
481 | Phosphorylation | GGRYVPGSSGSSNTL CCCCCCCCCCCCCCC | 26.00 | 30242111 | |
482 | Phosphorylation | GRYVPGSSGSSNTLP CCCCCCCCCCCCCCC | 48.92 | 26657352 | |
484 | Phosphorylation | YVPGSSGSSNTLPTA CCCCCCCCCCCCCCC | 23.51 | 26657352 | |
485 | Phosphorylation | VPGSSGSSNTLPTAD CCCCCCCCCCCCCCC | 37.04 | 30242111 | |
487 | Phosphorylation | GSSGSSNTLPTADPF CCCCCCCCCCCCCCC | 35.74 | 30242111 | |
490 | Phosphorylation | GSSNTLPTADPFTGA CCCCCCCCCCCCCCC | 46.97 | 27251275 | |
495 | Phosphorylation | LPTADPFTGAGRYVP CCCCCCCCCCCCCCC | 31.35 | 30242111 | |
500 | Phosphorylation | PFTGAGRYVPGSASM CCCCCCCCCCCCCCC | 15.30 | 21945579 | |
504 | Phosphorylation | AGRYVPGSASMGTTM CCCCCCCCCCCCCCC | 15.88 | 21945579 | |
506 | Phosphorylation | RYVPGSASMGTTMAG CCCCCCCCCCCCCCC | 21.31 | 21945579 | |
506 | Ubiquitination | RYVPGSASMGTTMAG CCCCCCCCCCCCCCC | 21.31 | 23000965 | |
509 | Phosphorylation | PGSASMGTTMAGVDP CCCCCCCCCCCCCCC | 12.54 | 21945579 | |
510 | Phosphorylation | GSASMGTTMAGVDPF CCCCCCCCCCCCCCC | 10.17 | 21945579 | |
514 | Ubiquitination | MGTTMAGVDPFTGNS CCCCCCCCCCCCCCH | 6.49 | 29967540 | |
515 | Ubiquitination | GTTMAGVDPFTGNSA CCCCCCCCCCCCCHH | 31.51 | 29967540 | |
518 | Phosphorylation | MAGVDPFTGNSAYRS CCCCCCCCCCHHHHH | 40.62 | 21945579 | |
521 | Phosphorylation | VDPFTGNSAYRSAAS CCCCCCCHHHHHHHC | 28.20 | 21945579 | |
523 | Phosphorylation | PFTGNSAYRSAASKT CCCCCHHHHHHHCCE | 12.62 | 21945579 | |
529 | Acetylation | AYRSAASKTMNIYFP HHHHHHCCEEEEEEC | 47.25 | 19608861 | |
529 | Ubiquitination | AYRSAASKTMNIYFP HHHHHHCCEEEEEEC | 47.25 | 23000965 | |
531 | Ubiquitination | RSAASKTMNIYFPKK HHHHCCEEEEEECCC | 3.10 | 23503661 | |
533 | Ubiquitination | AASKTMNIYFPKKEA HHCCEEEEEECCCCC | 2.32 | 27667366 | |
537 | Ubiquitination | TMNIYFPKKEAVTFD EEEEEECCCCCEECC | 54.04 | 29967540 | |
538 | Ubiquitination | MNIYFPKKEAVTFDQ EEEEECCCCCEECCC | 51.66 | 21906983 | |
543 | Ubiquitination | PKKEAVTFDQANPTQ CCCCCEECCCCCHHH | 5.42 | 27667366 | |
544 | Ubiquitination | KKEAVTFDQANPTQI CCCCEECCCCCHHHH | 37.00 | 29967540 | |
554 | Ubiquitination | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 23503661 | |
554 | Acetylation | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 23954790 | |
554 | Malonylation | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 26320211 | |
556 | Ubiquitination | TQILGKLKELNGTAP HHHHHHHHHHCCCCC | 64.74 | 27667366 | |
566 | Ubiquitination | NGTAPEEKKLTEDDL CCCCCHHHCCCHHHH | 51.96 | 27667366 | |
567 | Ubiquitination | GTAPEEKKLTEDDLI CCCCHHHCCCHHHHH | 65.01 | 22053931 | |
590 | Ubiquitination | ICNSSSEKPTVQQLQ HHCCCCCCCCHHHHH | 48.19 | 21906983 | |
599 | Ubiquitination | TVQQLQILWKAINCP CHHHHHHHHHHCCCC | 2.18 | 23000965 | |
605 | Glutathionylation | ILWKAINCPEDIVFP HHHHHCCCCHHHHHH | 2.97 | 22555962 | |
611 | Ubiquitination | NCPEDIVFPALDILR CCCHHHHHHHHHHHH | 2.75 | 32015554 | |
622 | Ubiquitination | DILRLSIKHPSVNEN HHHHHHCCCCCCCCC | 46.19 | 23000965 | |
627 | Ubiquitination | SIKHPSVNENFCNEK HCCCCCCCCCCCCHH | 42.71 | 29967540 | |
629 | Ubiquitination | KHPSVNENFCNEKEG CCCCCCCCCCCHHHH | 41.38 | 22505724 | |
634 | Ubiquitination | NENFCNEKEGAQFSS CCCCCCHHHHCHHHH | 47.67 | 32015554 | |
650 | Ubiquitination | LINLLNPKGKPANQL HHHHHCCCCCCHHHH | 77.74 | 29967540 | |
652 | Ubiquitination | NLLNPKGKPANQLLA HHHCCCCCCHHHHHH | 47.27 | 22505724 | |
652 | Malonylation | NLLNPKGKPANQLLA HHHCCCCCCHHHHHH | 47.27 | 26320211 | |
668 | Ubiquitination | RTFCNCFVGQAGQKL HHHHHHHHHHHHHHH | 6.39 | 29967540 | |
678 | Phosphorylation | AGQKLMMSQRESLMS HHHHHHHHHHHHHHH | 16.48 | - | |
682 | Phosphorylation | LMMSQRESLMSHAIE HHHHHHHHHHHHHHH | 31.40 | 29083192 | |
691 | Acetylation | MSHAIELKSGSNKNI HHHHHHHCCCCCCCH | 39.72 | 20167786 | |
691 | Ubiquitination | MSHAIELKSGSNKNI HHHHHHHCCCCCCCH | 39.72 | 2190698 | |
750 | Ubiquitination | FRLLVALGTLISDDS HHHHHHHHHHHCCCC | 14.56 | 27667366 | |
751 | Ubiquitination | RLLVALGTLISDDSN HHHHHHHHHHCCCCC | 23.05 | 29967540 | |
760 | Ubiquitination | ISDDSNAVQLAKSLG HCCCCCHHHHHHHCC | 5.84 | 29967540 | |
773 | Ubiquitination | LGVDSQIKKYSSVSE CCCCHHHHHCCCCCC | 37.71 | 27667366 | |
774 | Ubiquitination | GVDSQIKKYSSVSEP CCCHHHHHCCCCCCC | 52.58 | 29967540 | |
776 | Phosphorylation | DSQIKKYSSVSEPAK CHHHHHCCCCCCCHH | 32.89 | 20860994 | |
783 | Ubiquitination | SSVSEPAKVSECCRF CCCCCCHHHHHHHHH | 57.94 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLAP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLAP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLAP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TERA_HUMAN | VCP | physical | 19887378 | |
UBC_HUMAN | UBC | physical | 19423704 | |
PDIA3_HUMAN | PDIA3 | physical | 22484374 | |
CAV1_HUMAN | CAV1 | physical | 22484374 | |
NSF1C_HUMAN | NSFL1C | physical | 22863883 | |
PARP6_HUMAN | PARP6 | physical | 22863883 | |
PCNA_HUMAN | PCNA | physical | 22863883 | |
TBB2A_HUMAN | TUBB2A | physical | 22863883 | |
EFTU_HUMAN | TUFM | physical | 22863883 | |
TWF2_HUMAN | TWF2 | physical | 22863883 | |
UBXN1_HUMAN | UBXN1 | physical | 22863883 | |
UBXN1_HUMAN | UBXN1 | physical | 25416956 | |
BASP1_HUMAN | BASP1 | physical | 26344197 | |
XPO2_HUMAN | CSE1L | physical | 26344197 | |
FPPS_HUMAN | FDPS | physical | 26344197 | |
PAK2_HUMAN | PAK2 | physical | 26344197 | |
SF01_HUMAN | SF1 | physical | 26344197 | |
XPP1_HUMAN | XPNPEP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-529, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND MASSSPECTROMETRY. |